Hennion & Walsh Asset Management Inc. decreased its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 1.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,974 shares of the financial services provider’s stock after selling 185 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in CME Group were worth $2,548,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also modified their holdings of the stock. Truvestments Capital LLC acquired a new position in CME Group during the 3rd quarter worth approximately $26,000. Dunhill Financial LLC increased its holdings in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares during the last quarter. Fortitude Family Office LLC raised its stake in CME Group by 120.3% in the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares during the last quarter. Finally, Anchor Investment Management LLC boosted its position in shares of CME Group by 52.4% during the 3rd quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 130 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CME has been the subject of several recent analyst reports. TD Cowen assumed coverage on CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 target price for the company. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Piper Sandler upped their target price on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Monday, January 6th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $229.27.
CME Group Stock Up 0.2 %
CME opened at $232.71 on Friday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $249.02. The business has a 50 day moving average price of $233.15 and a two-hundred day moving average price of $219.51. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $83.86 billion, a PE ratio of 24.47, a P/E/G ratio of 4.93 and a beta of 0.56.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, research analysts anticipate that CME Group Inc. will post 10.2 EPS for the current year.
CME Group Increases Dividend
The company also recently announced a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were issued a $5.80 dividend. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date of this dividend was Friday, December 27th. CME Group’s payout ratio is presently 48.37%.
CME Group announced that its board has initiated a share buyback plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its shares are undervalued.
Insider Transactions at CME Group
In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at approximately $2,403,279.44. The trade was a 8.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,274 shares of company stock worth $1,648,071 over the last ninety days. 0.30% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Canadian Penny Stocks: Can They Make You Rich?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to Find Undervalued Stocks
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.